Skip to main content

TABLE 2 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma

Publication ,  Other
Chaudhary, R; Slebos, RJC; Noel, LC; Song, F; Poole, MI; Hoening, DS; Hernandez-Prera, JC; Conejo-Garcia, JR; Guevara-Patino, JA; Wang, X ...
May 22, 2023

<p>Disease control given pembrolizumab or nivolumab monotherapy in Moffitt retrospective study cohort</p>

Duke Scholars

DOI

Publication Date

May 22, 2023
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chaudhary, R., Slebos, R. J. C., Noel, L. C., Song, F., Poole, M. I., Hoening, D. S., … Chung, C. H. (2023). TABLE 2 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma. https://doi.org/10.1158/2767-9764.23057170
Chaudhary, Ritu, Robbert J. C. Slebos, Leenil C. Noel, Feifei Song, Maria I. Poole, Dirk S. Hoening, Juan C. Hernandez-Prera, et al. “TABLE 2 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma,” May 22, 2023. https://doi.org/10.1158/2767-9764.23057170.
Chaudhary R, Slebos RJC, Noel LC, Song F, Poole MI, Hoening DS, Hernandez-Prera JC, Conejo-Garcia JR, Guevara-Patino JA, Wang X, Xie M, Tan AC, Chung CH. TABLE 2 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma. 2023.

DOI

Publication Date

May 22, 2023